Boswellic acid has anti‐inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells

2019 ◽  
Vol 33 (6) ◽  
pp. 1670-1682 ◽  
Author(s):  
Manlio Barbarisi ◽  
Alfonso Barbarisi ◽  
Gabriele De Sena ◽  
Emilia Armenia ◽  
Caterina Aurilio ◽  
...  
1997 ◽  
Vol 94 (7) ◽  
pp. 3250-3255 ◽  
Author(s):  
D. M. O'Rourke ◽  
X. Qian ◽  
H.-T. Zhang ◽  
J. G. Davis ◽  
E. Nute ◽  
...  

2013 ◽  
Vol 38 (11) ◽  
pp. 2313-2322 ◽  
Author(s):  
Gangadhara Reddy Sareddy ◽  
Divya Kesanakurti ◽  
Puligurtha Bharadhwaja Kirti ◽  
Phanithi Prakash Babu

2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Özlem Özdemir ◽  
Lisa Marinelli ◽  
Ivana Cacciatore ◽  
Michele Ciulla ◽  
Bugrahan Emsen ◽  
...  

AbstractSeveral epidemiologic, clinical and experimental reports indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) could have a potential as anticancer agents. The aim of this study was the evaluation of cytotoxic potential in human glioblastoma cells of novel synthesized NSAID derivatives, obtained by linking, through a spacer, α-lipoic acid (ALA) to anti-inflammatory drugs, such as naproxen (AL-3, 11 and 17), flurbiprofen (AL-6, 13 and 19) and ibuprofen (AL-9, 15 and 21). The effects on the level of gene expression were also determined using quantitative real-time polymerase chain reaction (qRT-PCR) analysis. According to our results, NSAID derivatives exhibited concentration dependent cytotoxic effects on U87-MG cell line when compared with the control group. Moreover, treatment of the most active compounds (AL-3, AL-6 and AL-9) caused upregulation of tumor suppressor gene PTEN and downregulation of some oncogenes such as AKT1, RAF1 and EGFR. In conclusion, our results revealed that AL-3, AL-6 and AL-9 could be suitable candidates for further investigation to develop new pharmacological strategies for the prevention of cancer.


2021 ◽  
Vol 22 (21) ◽  
pp. 11938
Author(s):  
Luca X. Zampieri ◽  
Martina Sboarina ◽  
Andrea Cacace ◽  
Debora Grasso ◽  
Léopold Thabault ◽  
...  

Glioblastoma represents the highest grade of brain tumors. Despite maximal resection surgery associated with radiotherapy and concomitant followed by adjuvant chemotherapy with temozolomide (TMZ), patients have a very poor prognosis due to the rapid recurrence and the acquisition of resistance to TMZ. Here, initially considering that TMZ is a prodrug whose activation is pH-dependent, we explored the contribution of glioblastoma cell metabolism to TMZ resistance. Using isogenic TMZ-sensitive and TMZ-resistant human glioblastoma cells, we report that the expression of O6-methylguanine DNA methyltransferase (MGMT), which is known to repair TMZ-induced DNA methylation, does not primarily account for TMZ resistance. Rather, fitter mitochondria in TMZ-resistant glioblastoma cells are a direct cause of chemoresistance that can be targeted by inhibiting oxidative phosphorylation and/or autophagy/mitophagy. Unexpectedly, we found that PARP inhibitor olaparib, but not talazoparib, is also a mitochondrial Complex I inhibitor. Hence, we propose that the anticancer activities of olaparib in glioblastoma and other cancer types combine DNA repair inhibition and impairment of cancer cell respiration.


2019 ◽  
Vol Volume 13 ◽  
pp. 1023-1032 ◽  
Author(s):  
Jingren Shi ◽  
Wenli Zhang ◽  
Lu He ◽  
Fanhong Kong ◽  
Meichen Pan ◽  
...  

2007 ◽  
Vol 254 (1) ◽  
pp. 54-62 ◽  
Author(s):  
Sami Benzina ◽  
Frederic Debomy ◽  
Jean-Pierre Bergerat ◽  
Jean-Marc Denis ◽  
John Gueulette ◽  
...  

2012 ◽  
Vol 138 (11) ◽  
pp. 1831-1844 ◽  
Author(s):  
Berrin Tunca ◽  
Gulcin Tezcan ◽  
Gulsah Cecener ◽  
Unal Egeli ◽  
Secil Ak ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document